Aytu Biopharma (AYTU) Debt to Equity (2011 - 2026)
Aytu Biopharma (AYTU) reported Debt to Equity of $0.57 for Q1 2026, up 73.99% year-over-year from $0.33 in Q1 2025, and down 31.96% quarter-over-quarter from $0.83 in Q4 2025.
Aytu Biopharma (AYTU) Debt to Equity (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 15 years of Debt to Equity data on file, last reported at $0.57 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.57, up 73.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.57 (up 73.99% YoY), and the FY2025 annual result was $0.67, up 46.34% from the prior year.
- Debt to Equity retreated to $0.57 in Q1 2026 per AYTU's latest filing, from $0.83 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.09 in Q3 2025 and troughed at $0.05 in Q1 2024.
- A 5-year average of $0.47 and a median of $0.41 in 2023 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2022 and 2024: Debt to Equity surged 2423.07% in 2022, then plunged 90.35% in 2024.
- A 5-year view of Debt to Equity shows it stood at $0.32 in 2022, then jumped by 52.63% to $0.49 in 2023, then slipped by 21.0% to $0.38 in 2024, then surged by 116.91% to $0.83 in 2025, then slumped by 31.96% to $0.57 in 2026.
- Business Quant data shows AYTU's Debt to Equity at $0.57 in Q1 2026, $0.83 in Q4 2025, and $1.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | 0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.57 |
| Dec 31, 2025 | 0.83 |
| Sep 30, 2025 | 1.09 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.33 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.46 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.46 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.32 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.41 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.06 |